- TM Capital, together with our M&A International partner IBI Corporate Finance of Ireland, advised Eschmann Holdings Limited on its sale to STERIS Corporation (NYSE: STE)
- Eschmann, based in the United Kingdom, designs and manufactures a broad range of surgical and infection prevention products
- STERIS is a global leader in infection prevention, contamination control, surgical and critical care technologies with a market value of $3 billion
- STERIS acquired Eschmann for approximately $40 million in cash from Sisk Healthcare, an Ireland-based medical diagnostic and therapeutics equipment company
Global,
Healthcare
|
Mergers & Acquisitions